1. Home
  2. TIL vs XHG Comparison

TIL vs XHG Comparison

Compare TIL & XHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • XHG
  • Stock Information
  • Founded
  • TIL 2018
  • XHG 2012
  • Country
  • TIL United States
  • XHG China
  • Employees
  • TIL N/A
  • XHG N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • XHG
  • Sector
  • TIL Health Care
  • XHG
  • Exchange
  • TIL Nasdaq
  • XHG NYSE
  • Market Cap
  • TIL 230.1M
  • XHG 65.5M
  • IPO Year
  • TIL 2021
  • XHG 2019
  • Fundamental
  • Price
  • TIL $24.49
  • XHG $1.40
  • Analyst Decision
  • TIL Buy
  • XHG
  • Analyst Count
  • TIL 5
  • XHG 0
  • Target Price
  • TIL $119.00
  • XHG N/A
  • AVG Volume (30 Days)
  • TIL 310.3K
  • XHG 121.9K
  • Earning Date
  • TIL 08-12-2025
  • XHG 07-18-2025
  • Dividend Yield
  • TIL N/A
  • XHG N/A
  • EPS Growth
  • TIL N/A
  • XHG N/A
  • EPS
  • TIL N/A
  • XHG N/A
  • Revenue
  • TIL N/A
  • XHG $41,110,414.00
  • Revenue This Year
  • TIL N/A
  • XHG N/A
  • Revenue Next Year
  • TIL N/A
  • XHG N/A
  • P/E Ratio
  • TIL N/A
  • XHG N/A
  • Revenue Growth
  • TIL N/A
  • XHG N/A
  • 52 Week Low
  • TIL $9.70
  • XHG $1.16
  • 52 Week High
  • TIL $92.00
  • XHG $1,200.00
  • Technical
  • Relative Strength Index (RSI)
  • TIL 47.69
  • XHG 37.77
  • Support Level
  • TIL $21.80
  • XHG $1.26
  • Resistance Level
  • TIL $26.91
  • XHG $1.37
  • Average True Range (ATR)
  • TIL 3.52
  • XHG 0.12
  • MACD
  • TIL -0.37
  • XHG 0.08
  • Stochastic Oscillator
  • TIL 35.14
  • XHG 42.02

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About XHG XCHANGE TEC.INC SPON ADS EACH REP 600000 SHS(POST SPLIT)

XChange Tec Inc, through its subsidiaries operates in insurance agency and insurance technology business. The company specialized in distributing automobile insurance policies at the earlier stage of business and subsequently expanded insurance product portfolio to include other types of insurance including life, health, group accident and other property related insurances. A maximum of the insurance purchased through platform and agency services is of automobile insurance.

Share on Social Networks: